Griffin P. Rodgers

Rodgers NIDDK

Griffin P. Rodgers is an American hematologist and physician-scientist known for his contributions to the field of sickle cell disease research. He currently serves as the Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH).

Early Life and Education

Rodgers was born in New Orleans, Louisiana. He earned his B.A. degree from Brown University and his M.D. degree from the Brown University Alpert Medical School. He also holds a M.B.A. from the Johns Hopkins University and a M.S. in Clinical Research from the National Institutes of Health.

Career

Rodgers began his career at the NIH, where he has held various positions. He is best known for his pioneering research in the treatment of sickle cell disease, particularly for developing the first effective therapy for the disease, hydroxyurea. His work has significantly improved the quality of life for patients suffering from this genetic disorder.

Research Contributions

Rodgers' research has focused on understanding the molecular mechanisms of sickle cell disease and developing new treatments. His work on hydroxyurea has been instrumental in reducing the frequency of painful crises and the need for blood transfusions in patients with the disease. He has published numerous articles in leading scientific journals and has been a keynote speaker at various international conferences.

Awards and Honors

Rodgers has received several prestigious awards for his contributions to medical science, including the American Society of Hematology's Ernest Beutler Lecture and Prize, and the National Medical Association's Scroll of Merit. He is also a member of the National Academy of Medicine.

Personal Life

Rodgers is married and has two children. He is actively involved in community service and mentoring young scientists.

See Also

• Sickle cell disease
• National Institute of Diabetes and Digestive and Kidney Diseases
• National Institutes of Health
• Hydroxyurea